8 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 8 of 8 clinical reviews.
A clinical guide to using Tresiba (insulin degludec) safely in geriatric patients, covering exercise timing, hypoglycemia risk, dose adjustments, and practical scheduling strategies for adults 65 and over.
A clinical guide to transitioning older adults (65+) onto Tresiba (insulin degludec), covering dose adjustments, hypoglycemia risk, monitoring protocols, and ADA/AACE guideline recommendations.
A clinical guide to using Tresiba (insulin degludec) in children under 12 with type 1 diabetes, covering dosing, safety data, and the step-by-step process for transitioning young patients to adult endocrinology care.
A clinical deep-dive into off-label insulin degludec (Tresiba) use in children younger than 12, covering the evidence base, dosing considerations, safety data, and how it compares to approved basal insulins in this age group.
A guide for caregivers and adolescent patients on administering Tresiba (insulin degludec) safely. Covers injection technique, dosing timing, storage, missed doses, and how to involve teens in self-management.
A clinical deep-dive into how insulin degludec (Tresiba) affects adolescents aged 12 to 17, covering glycemic control, growth, puberty, hypoglycemia risk, and practical dosing guidance backed by primary-source evidence.
Complete caregiver guide to administering insulin degludec (Tresiba) in children under 12: correct dosing steps, injection technique, storage, hypoglycemia management, and safety monitoring backed by FDA labeling and ADA pediatric standards.
A guide to how Tresiba (insulin degludec) affects growth, neurodevelopment, and glycemic control in children younger than 12, with trial data, dosing guidance, and safety considerations.